ETG — Eaton Vance Tax-Advantaged Global Dividend Income Fund
—
NYSE ·
Unknown ·
Unknown ·
CIK 1270523 ·
Last close
$23.36
Market Cap
$1.78B
52W High
$23.76
52W Low
$20.78
ADV30
107,548
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Apr 2026 | — | — | — | — | 2,255,357,649 | 4,355,402 | 375,369,802 |
| Oct 2025 | — | — | — | — | 2,147,493,726 | 238,219 | 374,814,021 |
| Apr 2025 | — | — | — | — | 1,881,423,877 | 103,526 | 373,890,226 |
| Oct 2024 | — | — | — | — | 1,940,222,765 | 532,533 | 374,380,560 |
Balance + Analyst (yfinance extras)
Retained Earnings
$469,792,224
Inventory
—
Receivables
$9,925,621
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$86,440,824
EBITDA
—
Free Cash Flow
$50,131,584
Enterprise Value
$2,150,813,952
Total Cash
$4,355,402
Total Debt
$370,000,000
Shares Out
76,321,908
Trailing EPS
$6.43
Book Value
$24.63
ROE
29.0%
ROA
2.0%
Div Yield
6.63%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Oct 2025 | 326,494,921 | — | 325,258,573 | 2,147,493,726 | 374,814,021 | — | 118,126,759 |
| Oct 2024 | 392,839,595 | — | 391,451,754 | 1,940,222,765 | 374,380,560 | — | 110,340,084 |
| Oct 2023 | 153,437,003 | — | 152,141,322 | 1,667,703,134 | 383,334,031 | — | 91,922,263 |
| Oct 2022 | -383,460,119 | — | -384,631,500 | 1,596,974,875 | 372,904,596 | — | 116,918,797 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| GEL | GENESIS ENERGY LP | $1.78B | $14.56 | — |
| GDV-PH | GABELLI DIVIDEND & INCOME TRUST | $1.78B | $21.61 | — |
| ETV | Eaton Vance Tax-Managed Buy-Write Opportunities Fund | $1.78B | $15.25 | — |
| PAEXY | Parex Resources Inc./ADR | $1.79B | $18.63 | — |
| JHPCY | Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR | $1.76B | $13.60 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.